Transurethral Resection of The Prostate Market
Report ID: SQMIG35A3229
Report ID: SQMIG35A3229
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35A3229 |
Region:
Global |
Published Date: February, 2026
Pages:
157
|Tables:
119
|Figures:
77
Global Transurethral Resection Of The Prostate Market size was valued at USD 980.4 Million in 2024 and is poised to grow from USD 1031.38 Million in 2025 to USD 1547.19 Million by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).
Transurethral resection of the prostate (TURP) market is driven primarily by demographic shifts toward older male populations and rising incidence of benign prostatic hyperplasia, which together increase demand for surgical intervention. As a core endoscopic procedure for relieving urinary obstruction, the market matters because it represents both a standard of care and a platform for adjacent device innovation. Historically TURP evolved from monopolar cutting techniques to bipolar systems and competing laser enucleation options, prompting manufacturers and hospitals to invest in upgrades; for example, the late 1990s shift to bipolar technologies reduced complications and spurred replacement cycles and expanded global adoption.Building on that technological momentum, the factor propelling global TURP demand is innovation in energy platforms and perioperative workflows because improved devices reduce complications and shorten recovery, encouraging wider clinician adoption. As bleeding and TUR syndrome risks declined, more centers transitioned procedures to day surgery settings, which lowered costs and increased throughput; hospitals in Europe and North America report shorter catheterization times and same day discharges as common outcomes. Consequently manufacturers can capture value by bundling consumables while funding training and proctoring programs, enabling expansion into emerging markets where upgrading from open surgery yields measurable cost-effectiveness and scalable health benefits.
How is AI transforming surgical precision in the transurethral resection of the prostate market?
AI is sharpening surgical precision in the transurethral resection of the prostate market by improving imaging fusion, real time guidance and intraoperative decision support. Key aspects include better lesion localization, automated mapping of prostate anatomy and instrument tracking that reduces operator variability. The current state shows clinicians combining preoperative MRI with live ultrasound and AI driven models to translate diagnostic images into actionable targets. These tools integrate with navigation and robotic systems to make resections more consistent and tissue sparing. The result is a shift toward safer, less invasive interventions and smoother workflows for surgical teams.Profound Medical November 2025, introduced an AI powered TULSA volume reduction module that automates planning and optimizes ablation. This real world innovation supports market efficiency by shortening planning time and enabling multiple same day procedures while improving procedural consistency across patients.
Market snapshot - (2026-2033)
Global Market Size
USD 980.4 Million
Largest Segment
Consumables and Accessories
Fastest Growth
Laser Instruments
Growth Rate
5.2% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global transurethral resection of the prostate market is segmented by product type, technology, application, end user and region. Based on product type, the market is segmented into Monopolar Resectoscope, Bipolar Resectoscope, Laser Instruments and Consumables and Accessories. Based on technology, the market is segmented into Monopolar Technology, Bipolar Technology and Laser Technology. Based on application, the market is segmented into Benign Prostatic Hyperplasia (BPH), Prostate Cancer and Others. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Urology Clinics and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Bipolar Resectoscope segment dominates because its inherent safety profile and compatibility with saline irrigation reduce perioperative risks, enabling surgeons to treat larger prostates with lower bleeding and improved visibility. This technical advantage fosters wider adoption among urologists and hospitals, driving procurement preference and clinical guideline endorsement. The result is sustained demand as clinicians prioritize devices that lower complications, shorten recoveries, and integrate with existing electrosurgical workflows, reinforcing market leadership.
However, Laser Instruments are the most rapidly expanding area because their minimally invasive profile, precision tissue ablation, and reduced bleeding encourage adoption across diverse practice settings. Ongoing innovation in laser platforms and procedural protocols is expanding application to larger prostates and complex cases, attracting investment and creating future opportunities for new device entrants.
Hospitals segment dominates because they concentrate multidisciplinary infrastructure, advanced perioperative support, and high surgical throughput that accommodate complex transurethral resections and manage complications. Established referral pathways and clinician familiarity lead to consistent procedure volumes, enabling investment in specialized resection systems and staff training. This ecosystem drives procurement decisions toward hospital settings where comprehensive care continuity, credentialing standards, and postprocedure monitoring align with clinician and payer expectations, sustaining leadership in market utilization.
Meanwhile, Ambulatory Surgical Centers are the fastest growing care setting due to streamlined workflows, lower overhead, and tailored perioperative pathways that support same day transurethral resections. Increasing clinician preference for outpatient procedures, coupled with investment in portable resection technologies and focused reimbursement models, is accelerating adoption and expanding opportunities for specialized providers and equipment suppliers.
To get detailed segments analysis, Request a Free Sample Report
North America maintains dominance through a convergence of strengths across clinical, commercial, and regulatory dimensions. A dense concentration of leading device manufacturers and specialty hospitals drives rapid translation of innovation into practice, supported by comprehensive reimbursement frameworks and established procurement channels. Strong clinical expertise and high procedure adoption rates enable continuous refinement of techniques and technologies. Collaborative networks among academic centers, industry, and professional societies foster robust evidence generation and training programs that accelerate clinician uptake. Investment in research and development, coupled with a favorable regulatory environment for market entry and postmarket surveillance, sustains leadership and attracts global attention, reinforcing a virtuous cycle of innovation and clinical diffusion.
Transurethral Resection of The Prostate Market in the United States is characterized by a mature ecosystem of academic urology centers, specialized hospitals, and active device manufacturers. High clinician familiarity with advanced resection techniques and a supportive reimbursement landscape facilitate broad procedural availability across care settings. Strong clinical trial activity and continuing medical education programs reinforce evidence adoption and procedural refinement. Robust purchasing channels and strategic partnerships between industry and clinical stakeholders enable early access to new device iterations and procedural adjuncts.
Transurethral Resection of The Prostate Market in Canada reflects a health system oriented toward equitable access and standardized care pathways. Adoption is influenced by centralized policy decision making and provincial procurement strategies that emphasize clinical value and outcomes. Centers of excellence in urban regions provide concentrated clinical expertise and training opportunities, while collaboration between hospitals and manufacturers supports technology assessment and controlled rollout. The market balances innovation uptake with rigorous evaluation, resulting in steady integration of procedural advances into established urology services.
Rapid expansion in Europe is driven by coordinated healthcare delivery models, strong clinical networks, and growing emphasis on minimally invasive urological care. Centralized procurement and public reimbursement systems in many markets support structured adoption once clinical value is demonstrated. Active clinical research across academic hospitals and multicenter collaborations generates real world evidence that informs national guidelines and clinician practice. Cross border knowledge exchange and regional conferences accelerate dissemination of best practices. Expansion is further enabled by a competitive supplier landscape that tailors device offerings to diverse hospital budgets and operational needs, while targeted training initiatives reduce procedural variability and support broader clinical uptake.
Transurethral Resection of The Prostate Market in Germany is marked by a dominant position anchored in advanced hospital infrastructure and a high level of procedural specialization. German urology departments engage in extensive clinical evaluation and early adoption of device innovations, supported by strong relationships with manufacturers. Hospital reimbursement mechanisms and technology assessment pathways favor evidence based integration of new techniques. Robust training programs and regional centers of expertise ensure consistent procedural quality and sustain leadership in clinical practice and device utilization.
Transurethral Resection of The Prostate Market in the United Kingdom is experiencing rapid growth driven by focused policy initiatives and integration of innovation into care pathways. Both public and private providers are expanding access through regional centers and rapid dissemination of guideline informed practices. Investment in training and multidisciplinary collaboration enhances clinician confidence with newer procedural approaches. Procurement strategies that emphasize clinical outcomes alongside cost-effectiveness enable scalable adoption across hospital systems, supporting a dynamic expansion of service provision and technology uptake.
Transurethral Resection of The Prostate Market in France is emerging through modernization of hospital services and growing emphasis on evidence based urological care. Urban academic centers lead adoption and generate clinical data that informs broader practice. Reimbursement and approval pathways are evolving to accommodate innovations, and concerted training efforts aim to reduce regional variability in procedural availability. Partnerships between clinicians and industry support technology evaluation in real world settings, helping to transition promising techniques from specialist centers into wider clinical use.
Asia Pacific is strengthening its position through strategic investments in healthcare infrastructure, local manufacturing capabilities, and clinician training initiatives that enhance procedural capacity. Regional governments and private healthcare providers are prioritizing minimally invasive urology services, enabling wider adoption of advanced resection technologies. Collaborative arrangements between global manufacturers and local partners facilitate technology transfer and tailored solutions for diverse care settings. Growing clinical research activity and participation in international trials bolster regional expertise and credibility. Concentrated centers of excellence in key markets serve as hubs for training and dissemination, accelerating regional integration into the global market landscape.
Transurethral Resection of The Prostate Market in Japan is underpinned by a sophisticated healthcare system and high standards of clinical practice. Specialty urology centers emphasize procedural precision and outcome monitoring, while domestic manufacturers contribute to a vibrant device ecosystem. Regulatory and health technology assessment frameworks require rigorous evidence, shaping a cautious but steady adoption pathway. Strong professional networks and academic collaborations support continuous skills development and selective introduction of advanced resection modalities into routine clinical care.
Transurethral Resection of The Prostate Market in South Korea benefits from a technologically advanced hospital sector and proactive clinician engagement with new procedures. Private and public hospitals often act as early adopters, supported by close collaboration with device developers and focused training programs. A competitive healthcare equipment market encourages rapid iteration and customization of solutions to local clinical workflows. Emphasis on quality metrics and procedural outcomes drives hospitals to integrate proven innovations and build regional expertise that supports expanding service delivery.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Aging Population And BPH Prevalence
Advances In Surgical Technologies
High Procedure Costs And Reimbursement
Complication Risks And Outcomes
Request Free Customization of this report to help us to meet your business objectives.
Competition in the global transurethral resection of the prostate market is intensifying as incumbents and new entrants compete on minimally invasive substitutes, image guided robotics and office based therapies, driving M&A, strategic partnerships and targeted tech launches. Recent concrete moves include major acquisitions to add minimally invasive platforms, capital raises to scale robotic waterjet therapy, and commercialization of MRI guided transurethral ultrasound systems.
Top Player’s Company Profile
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. As per SkyQuest analysis, the global transurethral resection of the prostate market is driven by an aging population and rising benign prostatic hyperplasia prevalence, while advances in surgical technologies that improve safety and enable outpatient workflows act as a second important driver. However high procedure costs and uneven reimbursement represent a major restraint that can slow device adoption and service expansion. North America remains the dominating region due to concentrated device manufacturers, supportive reimbursement and strong clinical networks, and the bipolar resectoscope segment is the dominating product choice because of its improved safety profile and saline irrigation compatibility. Opportunities center on training, bundled consumables and ambulatory care expansion.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 980.4 Million |
| Market size value in 2033 | USD 1547.19 Million |
| Growth Rate | 5.2% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Transurethral Resection of The Prostate Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Transurethral Resection of The Prostate Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Transurethral Resection of The Prostate Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Transurethral Resection of The Prostate Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
